Regulatory Access Scendea operates as an international product development, regulatory and compliance consulting group serving the pharmaceutical and biotechnology industry, with team members across the US, Netherlands, Australia and the UK. This positions them to help potential customers navigate multi-jurisdictional regulatory pathways and achieve faster time-to-market.

End-to-End Support Their services span Non-Clinical, CMC, Clinical and Regulatory, plus GxP audits and QMS training through a dedicated Compliance division, enabling a one-stop solution for sponsors seeking seamless development, inspection readiness and quality framework implementation.

Collaborative Partnerships Recent partnerships and integrations with ERBC Group and Pharma Initiative Support indicate a strategy to enhance preclinical, regulatory and clinical strategy capabilities, suggesting opportunities to position Scendea as the coordinating hub for alliance-led drug development programs.

Growing Global Footprint With a global footprint and a moderate revenue range (1M–10M) and 51–200 employees, Scendea appears poised to scale services for mid-sized pharma and biotech firms pursuing international registrations and cross-border clinical trials.

Target Market Fit Serving pharmaceutical and biotechnology clients with high regulatory complexity, Scendea’s expertise aligns with CRO/CDMO oversight, quality management, and regulatory strategy needs of sponsors seeking compliance-driven development and market approval support.